Richard H. Stanford - US Value Evidence & Outcomes, GlaxoSmithKline Plc

基本信息

浏览量：46

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 276 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparative Effectiveness of Dupilumab and Omalizumab on Asthma Exacerbations and Systemic Corticosteroid Prescriptions: Real-World US ADVANTAGE Study

Eugene Bleecker,Michael Blaiss,Juby Jacob-Nara,Lynn Huynh,Mei Sheng Duh,Tracy Guo,Mingchen Ye,Richard H. Stanford,Zhixiao Wang,Xavier Soler,Arpita Nag,Radhika Nair,Kinga Borsos

Journal of Allergy and Clinical Immunology (2024)

引用0浏览0WOS引用

EE420 Development and Validation of a Markov Model for the Evaluation of a One-Time Universal Screening for Hepatitis B in Adults

A. Pan,R. H. Stanford,D. Gratie,L. Mody,T. K. Reinsch

Value in Healthno. 6 (2024): S134-S134

引用0浏览0引用

Dupilumab Asthma ADVANTAGE-EU: Real-World Evidence on the Association Between Dupilumab and Use of Corticosteroid and Asthma Exacerbations in Patients with Severe Asthma in Europe

A. Bourdin,G.W. Canonica,J.C. Virchow,J. Jacob-Nara, K. Borsos,R.H. Stanford,N. Pandit-Abid, Z. Wang,X. Soler,L. Huynh,S. Kalia,M.S. Duh,W.W.-H. Cheng

C102 CLINICAL AND TRANSLATIONAL ADVANCES IN ASTHMA (2024)

引用0浏览0引用

Real-world Effectiveness of Dupilumab Versus Benralizumab and Mepolizumab

Eugene Bleecker,Michael Blaiss,Juby Jacob-Nara,Lynn Huynh,Tracy Guo,Mingchen Ye,Richard H. Stanford,Zhixiao Wang,Xavier Soler,Arpita Nag,Radhika Nair,Kinga Borsos

ALLERGY AND ASTHMA PROCEEDINGSno. 4 (2024): 219-231

引用0浏览0WOS引用

AN ASSESSMENT OF EXACERBATION AND MORTALITY AMONG CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS BY BLOOD EOSINOPHILS AND DOUBLE/TRIPLE INHALER USE IN THE UNITED STATES

SURYA P BHATT, YIRAN ZHANG,JOHN C WHITE,RACHEL HALPERN,RICHARD H STANFORD, ERNESTO MAYEN HERRERA, DANEN CUNOOSAMY, XAVIER SOLER,MENA SOLIMAN,JIGNA HEBLE,MICHEL DJANDJI,TABARAK A QURESHI,ARUN SUBRAMANIAM

CHESTno. 4 (2024): A4878-A4879

引用0浏览0引用

Characterization of Chronic Obstructive Pulmonary Disease (COPD) in the United States

S.P. Bhatt, Y. Zhang, J. White, R. Halpern,R.H. Stanford, E. Mayen Herrera,X. Soler, M. Soliman,J. Heble,M. Djandji, T. Qureshi, A. Subramaniam

B51 LEVERAGING ADMINISTRATIVE AND LARGE DATASETS TO UNDERSTAND COPD EPIDEMIOLOGY (2024)

引用0浏览0引用

Characterization of Patients with Severe Asthma Who Initiated Biologic Treatment Within ≤90 and >90 Days after Biologic Eligibility

D. Do, N. Bieszk,R.H. Stanford,R. Lubwama, J. Ghekas, T. Lee, G. Jay, R. Mehta, D. Kennedy,W.W.-H. Cheng, N. Petruski-Ivleva

D22 ADVANCES IN HEALTH SERVICES RESEARCH IN ASTHMA (2024)

引用0浏览0引用

A 3-Year Descriptive Assessment of Exacerbations and Double/Triple Inhaler Use among Chronic Obstructive Pulmonary Disease (COPD) Patients in the United States (US)

S.P. Bhatt, Y. Zhang, J. White, R. Halpern,R.H. Stanford, E. Mayen Herrera,X. Soler, M. Soliman,J. Heble,M. Djandji, T. Qureshi, A. Subramaniam

B51 LEVERAGING ADMINISTRATIVE AND LARGE DATASETS TO UNDERSTAND COPD EPIDEMIOLOGY (2024)

引用0浏览0引用

Association Between Serial Spirometric Improver Phenotype (improved FEV1 over Time) Versus Decliner Phenotype in Healthcare Utilization in Chronic Obstructive Pulmonary Disease

R.A. Mularski, D. Nyongesa,R. Stanford,E. Mayen Herrera, K. Borsos, D. Sapp,P. Crawford,M.A. McBurnie

A35 ASTHMA AND COPD EPIDEMIOLOGY, TREATMENT, OUTCOMES, AND SOCIAL DETERMINANTS (2024)

引用0浏览0引用

Inhaled Corticosteroid/long-Acting Beta2-Agonist (ICS/LABA) New-User Analysis: Identifying Asthma-Exacerbation/short-acting Beta2-Agonist (SABA) Overuse-Associated Characteristics

Mohamed Hamouda,Jennifer Quint, Adrian Rendón,Richard Stanford, Bilun Gemicioglu, Leandro Fritscher, Watchara Boonsawat, Shireen Quli Khan

Monitoring airway disease (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn